Modern Healthcare Technology Holdings Limited

Symbol: 0919.HK

HKSE

0.085

HKD

Market price today

  • -0.5691

    P/E Ratio

  • -0.0081

    PEG Ratio

  • 76.88M

    MRK Cap

  • 0.00%

    DIV Yield

Modern Healthcare Technology Holdings Limited (0919-HK) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.04%

Operating Profit Margin

-0.19%

Net Profit Margin

-0.23%

Return on Assets

-0.21%

Return on Equity

-0.73%

Return on Capital Employed

-0.46%

Company general description and statistics

Sector: Consumer Cyclical
Industry: Personal Products & Services
CEO:Dr. Yue Tsang
Full-time employees:888
City:Kowloon Bay
Address:Sino Industrial Plaza
IPO:2006-02-09
CIK:

Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, the People's Republic of China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; and spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, foot treatment, and foot massage services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Cellnoc, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care brand names. In addition, it provides franchise and trademark services in relation to beautification and gymnastic services; advertising services; maid agency services; and management services, as well as food and beverage services. As of March 31, 2022, the company had 30 service centers in Hong Kong; 3 service centers in Mainland China; and 7 service centers in Singapore, as well as 8 be Beauty Shop outlets. Modern Healthcare Technology Holdings Limited is headquartered in Kowloon Bay, Hong Kong.

General Outlook

When we look at how much money they make before expenses, they keep 0.038% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.186%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.229%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.214% return, is a testament to Modern Healthcare Technology Holdings Limited's adeptness in optimizing resource deployment. Modern Healthcare Technology Holdings Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.732%. Furthermore, the proficiency of Modern Healthcare Technology Holdings Limited in capital utilization is underscored by a remarkable -0.462% return on capital employed.

Stock Prices

Modern Healthcare Technology Holdings Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.105, while its low point bottomed out at $0.105. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Modern Healthcare Technology Holdings Limited's stock market.

Liquidity Ratios

Analyzing 0919.HK liquidity ratios reveals its financial health of the firm. The current ratio of 93.22% gauges short-term asset coverage for liabilities. The quick ratio (78.50%) assesses immediate liquidity, while the cash ratio (50.59%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio93.22%
Quick Ratio78.50%
Cash Ratio50.59%

Profitability Ratios

0919.HK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -22.79% underscores its earnings before tax deductions. The effective tax rate stands at -0.64%, revealing its tax efficiency. The net income per EBT, 100.59%, and the EBT per EBIT, 122.74%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -18.57%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-22.79%
Effective Tax Rate-0.64%
Net Income per EBT100.59%
EBT per EBIT122.74%
EBIT per Revenue-18.57%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.93, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 564.22% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding78
Days of Inventory Outstanding6
Operating Cycle70.24
Days of Payables Outstanding1
Cash Conversion Cycle70
Receivables Turnover5.64
Payables Turnover538.63
Inventory Turnover65.77
Fixed Asset Turnover2.96
Asset Turnover0.93

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.20, and free cash flow per share, 0.19, depict cash generation on a per-share basis. The cash per share value, 0.23, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.31, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.20
Free Cash Flow per Share0.19
Cash per Share0.23
Operating Cash Flow Sales Ratio0.31
Free Cash Flow to Operating Cash Flow Ratio0.92
Cash Flow Coverage Ratio1.59
Short Term Coverage Ratio3.45
Capital Expenditure Coverage Ratio13.29
Dividend Paid and Capex Coverage Ratio13.29

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 18.39%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.68, we discern the balance between debt and equity financing. The long-term debt to capitalization, 26.96%, and total debt to capitalization, 40.64%, ratios shed light on its capital structure. An interest coverage of -4.09 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio18.39%
Debt Equity Ratio0.68
Long Term Debt to Capitalization26.96%
Total Debt to Capitalization40.64%
Interest Coverage-4.09
Cash Flow to Debt Ratio1.59
Company Equity Multiplier3.72

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 14.27%, indicates top-line expansion, while the gross profit growth, 15.58%, reveals profitability trends. EBIT growth, 83.51%, and operating income growth, 83.51%, offer insights into operational profitability progression. The net income growth, 70.05%, showcases bottom-line expansion, and the EPS growth, 70.04%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth14.27%
Gross Profit Growth15.58%
EBIT Growth83.51%
Operating Income Growth83.51%
Net Income Growth70.05%
EPS Growth70.04%
EPS Diluted Growth70.04%
Operating Cash Flow Growth172.51%
Free Cash Flow Growth524.84%
10-Year Revenue Growth per Share-44.55%
5-Year Revenue Growth per Share-32.25%
3-Year Revenue Growth per Share-22.25%
10-Year Operating CF Growth per Share274.89%
5-Year Operating CF Growth per Share636.76%
3-Year Operating CF Growth per Share118.79%
10-Year Net Income Growth per Share62.73%
5-Year Net Income Growth per Share9.95%
3-Year Net Income Growth per Share34.77%
10-Year Shareholders Equity Growth per Share32.78%
5-Year Shareholders Equity Growth per Share132.56%
3-Year Shareholders Equity Growth per Share36.09%
10-Year Dividend per Share Growth per Share-100.00%
5-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-15.62%
Inventory Growth-0.18%
Asset Growth-1.68%
Book Value per Share Growth-9.02%
Debt Growth-38.30%
SGA Expenses Growth12.29%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.45, and the price to book ratio, 0.45, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.13, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 0.45, and price to operating cash flows, 0.42, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.45
Price to Book Ratio0.45
Price to Sales Ratio0.13
Price Cash Flow Ratio0.42
Price Earnings to Growth Ratio-0.01
Enterprise Value Multiple-8.11
Price Fair Value0.45
Price to Operating Cash Flow Ratio0.42
Price to Free Cash Flows Ratio0.45
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Modern Healthcare Technology Holdings Limited (0919.HK) on the HKSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.569 in 2024.

What is the ticker symbol of Modern Healthcare Technology Holdings Limited stock?

The ticker symbol of Modern Healthcare Technology Holdings Limited stock is 0919.HK.

What is company IPO date?

IPO date of Modern Healthcare Technology Holdings Limited is 2006-02-09.

What is company current share price?

Current share price is 0.085 HKD.

What is stock market cap today?

The market cap of stock today is 76881140.000.

What is PEG ratio in 2024?

The current -0.008 is -0.008 in 2024.

What is the number of employees in 2024?

In 2024 the company has 888.